Vericel Corporation (VCEL) vs Viridian Therapeutics, Inc. (VRDN)
- Vericel Corporation VCEL 40.13 −2.17%
- Viridian Therapeutics, Inc. VRDN 19.03 −2.71%
Vericel Corporation and Viridian Therapeutics, Inc. are both Biotechnology companies. Vericel Corporation and Viridian Therapeutics, Inc. are of similar size ($2.2B and $2.1B). Viridian Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 83.6×. Viridian Therapeutics, Inc. grew revenue faster over the last twelve months: 23,220.3% against 23.0%. Vericel Corporation has the higher net margin (7.91% vs −544.1%) and the higher return on invested capital (5.49% vs 0.00%). Across the 19 metrics below, Vericel Corporation leads on 14 and Viridian Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | VCEL | VRDN | Biotechnology median |
|---|---|---|---|
| Gross margin | 74.56% | 100.00% | 65.16% |
| Operating margin | 5.95% | (569.68%) | 0.00% |
| Net margin | 7.91% | (544.06%) | 0.00% |
| Free cash flow margin | 20.13% | (471.04%) | 0.00% |
| Return on equity | 7.16% | (86.93%) | (56.36%) |
| Return on assets | 5.16% | (46.08%) | (48.04%) |
| Return on invested capital | 5.49% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack